期刊文献+

Efficacy and safety of a novel multi-electrode radiofrequency ablation catheter for renal sympathetic denervation in pigs 被引量:1

Efficacy and safety of a novel multi-electrode radiofrequency ablation catheter for renal sympathetic denervation in pigs
下载PDF
导出
摘要 ObjectiveTo 调查一根自我开发的新奇多电极 radiofrequency 脱离导管(火花) 的安全和功效因为 14 头试验性的缩小的猪全部的基于导管的肾的 denervation (RDN ).MethodsA 随机被划分成四个组(55 ° &5 瓦特, 55 ° &8 瓦特, 65 ° &5 瓦特,和 65 °&8 瓦特组) 。火花被用于左和恰好肾的动脉 radiofrequency 脱离。象肾的动脉X线摄影法一样从肾的动脉和静脉收集的血样品以前在所有动物上被执行,立即在以后,并且在过程到以后的三个月评估血浆高血压蛋白原酶的火花 on the levels 的效果,醛固酮,血管收缩素我,并且象肾的 arteries.ResultsOne 猪的病理学的变化一样的血管收缩素 II 死于一个麻药事故, 13 头猪成功地经历了双边的肾的动脉脱离。与基本大小相比,在所有四个组的猪显著地减少了在过程以后的吝啬的动脉的压力。组织病理学说的分析证明这个过程能导致内层的增生,在象在 perineurium 的煽动性的细胞渗入和纤维变性那样的肾的动脉的重要外部同情的神经损坏,神经纤维的不平的分发,织物坏死,严重 vacuolization ,碎裂并且不清楚的 nucleoli 髓磷脂退化,稀少的轴突,并且连续性的打断。另外,肾的动脉 radiofrequency 脱离能显著地减少血浆高血压蛋白原酶的层次,醛固酮,血管收缩素我,和在 pigs.ConclusionsThe 结果的血管收缩素 II 建议那基于导管的 radiofrequency 脱离能有效地移开的这类多电极外部肾的同情的神经和还原剂在猪的全身的高血压蛋白原酶血管收缩素系统的活动,因此在猪便于全身的血压的控制。 Objective To investigate the safety and efficacy of a self-developed novel multi-electrode radiofrequency ablation catheter (Spark) for catheter-based renal denervation (RDN). Methods A total of 14 experimental miniature pigs were randomly divided into four groups (55°& 5-watt, 55°& 8-watt, 65°& 5-watt, and 65° & 8-watt groups). Spark was used for left and right renal artery radiofrequency ablation. Blood samples collected from renal arteries and veins as well as renal arteriography were performed on all animals before, immediately after, and three months after procedure to evaluate the effects of Spark on the levels of plasma renin, aldosterone, angiotensin I, and angiotensin II as well as the pathological changes of renal arteries. Results One pig died of an anesthetic accident, 13 pigs successfully underwent the bilateral renal artery ablation. Compared with basic measurements, pigs in all the four groups had significantly decreased mean arterial pres- sure after procedure. Histopathological analysis showed that this procedure could result in intimal hyperplasia, significant peripheral sympa- thetic nerve damage in the renal arteries such as inflammatory cell infiltration and fibrosis in perineurium, uneven distribution of nerve fibers, tissue necrosis, severe vacuolization, fTagmented and unclear nucleoli myelin degeneration, sparse axons, and interruption of continuity. In addition, the renal artery radiofrequency ablation could significantly reduce the levels of plasma renin, aldosterone, angiotensin I, and angio- tensin II in pigs. Conclusions The results suggest that this type of multi-electrode catheter-based radiofrequency ablation could effectively remove peripheral renal sympathetic nerves and reduce the activity of systemic renin-angiotensin system in pigs, thus facilitating the control of systemic blood pressure in pigs.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2015年第6期618-625,共8页 老年心脏病学杂志(英文版)
关键词 射频消融 神经损伤 猪肾脏 多电极 安全性 肾素-血管紧张素系统 导管 疗效 Multi-electrode catheter Radiofrequency ablation Renal artery
  • 相关文献

参考文献23

  • 1Vongpatanasin W. Resistant hypertension: a review of diag- nosis and management. JAMA 2014; 311: 2216-2224.
  • 2Persell S. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011; 57: 1076-1080.
  • 3Vink EE, Blankestijn PJ. Evidence and consequences of the central role of the kidneys in the pathophysiology of sympa- thetic hyperactivity. Front Physio12012; 3: 29.
  • 4Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-1281.
  • 5Krum H, Schlaich M, Whitboum R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: du- rability of blood pressure reduction out to 24 months. Hyper- tension 2011; 57:911-917.
  • 6Krum H, Schlaich MP, Bohm M, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014; 383: 622-629.
  • 7Syrnplicity HTN-2 Investigators, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treat- ment-resistant hypertension (The Symplicity HTN-2 Trial): a randomized controlled trial. Lancet 2010; 376: 1903-1909.
  • 8Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension. One-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012; 126: 2976-2982.
  • 9Azizi M, Sapoval M, Gosse P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 2015; 385: 1957-1965.
  • 10Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension: rationale and de- sign of the Symplicity HTN-3 Trial. Clin Cardiol 2012; 35: 528-535.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部